日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Flavonifractor Plautii or Its Metabolite Desaminotyrosine as Prophylactic Agents for Alleviating Myocardial Ischemia/Reperfusion Injury.

普氏黄酮或其代谢产物脱氨基酪氨酸作为预防心肌缺血/再灌注损伤的药物

Du Heng, Liu Xu, Shen Jianghua, Yuan Hailong, Zhang Hao, Xi Gan, Li Yujing, Wang Yuhan, Zhang Jiahe, Yang Chaofan, Xu Pengfei, Wang Jiawan, Wang Fang, Liu Siqi, Zhou Yanan, Gu Qi, Lu Jingjing, Wei Tuo, Gao Zeyu, Zang Jingyi, Wang Jun, Song Moshi

Integrated genomic analysis of NF1-associated peripheral nerve sheath tumors: an updated biorepository dataset.

NF1相关周围神经鞘瘤的综合基因组分析:更新的生物样本库数据集

Banerjee Jineta, Lyu Yang, Makri Stavriani C, Scott Alexandra J, Zhang Lindy, Calizo Ana, Pollard Kai, Yang Kuangying, Gross John M, Lucas Calixto-Hope G, Wang Jiawan, Levin Adam S, Belzberg Allan J, Romo Carlos G, Allaway Robert J, Blakeley Jaishri O, Hirbe Angela C, Pratilas Christine A

Selective inhibition of BRAF and CRAF sensitizes NF1-deficient malignant peripheral nerve sheath tumors to MEK inhibitors

选择性抑制BRAF和CRAF可使NF1缺陷型恶性周围神经鞘瘤对MEK抑制剂敏感。

Wang, Jiawan; Sarkar, Arnab; Garcia, Natalia; Zhang, Lindy; Calizo, Ana; Lisok, Alla; Campos, Katia; He, Funan; Punjaala, Nishanth; Marple, Teresa; Pollard, Kai; Zheng, Siyuan; Lucas, Calixto-Hope G; Cooke, Vesselina G; Pratilas, Christine A; Vaseva, Angelina V

Combined inhibition of SHP2 overcomes adaptive resistance to type 1 BRAF inhibitors in BRAF V600E-driven high-grade glioma.

联合抑制 SHP2 可克服 BRAF V600E 驱动的高级别胶质瘤对 1 型 BRAF 抑制剂的适应性耐药性

Ayanlaja Abiola A, Chang Michael, Lalwani Kriti, Ioannou Maria, Wang Jiawan, Jagtap Shreya, Yang Yanbo, Lucas Calixto-Hope G, Mulcahy-Levy Jean M, Gartrell Robyn D, Pratilas Christine A, Schreck Karisa C

Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor Microenvironment

人类NF1相关周围神经鞘瘤的多维免疫分型揭示肿瘤相关巨噬细胞是肿瘤微环境中免疫逃逸的关键驱动因素

Zhang, Lindy; Maalouf, Alexandre; Makri, Stavriani C; Banerjee, Jineta; Suru, Aditya; Tam, Ada J; Calizo, Ana; Pollard, Kai; Wang, Jiawan; Danilova, Ludmila; Ioannou, Maria; Levin, Adam S; Morris, Carol D; Rhee, Daniel S; Belzberg, Allan J; Blakeley, Jaishri O; Ladle, Brian H; Pardoll, Drew M; Lucas, Calixto-Hope G; Rodriguez, Fausto J; Gross, John M; Anders, Robert A; Pratilas, Christine A; Llosa, Nicolas J

Mass intraoperative endothelial glycocalyx shedding affects postoperative systemic inflammation response

术中大量内皮糖萼脱落影响术后全身炎症反应

Wang, JiaWan; Wu, Yan

The predictive and prognostic value of risk factors in patients receiving hybrid coronary revascularization with postoperative pulmonary complications

风险因素对接受混合冠状动脉血运重建术后发生肺部并发症患者的预测和预后价值

Mu, Shanshan; Chen, Yingqi; Wang, Jiawan; Guo, Jingjing; Niu, Ruitong; Zhang, Yang; Su, Pixiong; Ali, Jason M; Gao, Jie; Wu, Anshi

Correction: Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma

更正:以法尼基化为靶点治疗HRAS突变型横纹肌肉瘤是一种新的治疗方法

Odeniyide, Patience; Yohe, Marielle E; Pollard, Kai; Vaseva, Angelina V; Calizo, Ana; Zhang, Lindy; Rodriguez, Fausto J; Gross, John M; Allen, Amy N; Wan, Xiaolin; Somwar, Romel; Schreck, Karisa C; Kessler, Linda; Wang, Jiawan; Pratilas, Christine A

From Genes to -Omics: The Evolving Molecular Landscape of Malignant Peripheral Nerve Sheath Tumor

从基因到组学:恶性周围神经鞘瘤不断演变的分子图谱

Lemberg, Kathryn M; Wang, Jiawan; Pratilas, Christine A

FLT3-IRAK dual targeting: an exciting new therapeutic option guided by adaptive activation of immune response pathways

FLT3-IRAK双重靶向:一种由免疫反应通路适应性激活指导的令人兴奋的新治疗选择

Rabik, Cara A; Wang, Jiawan; Pratilas, Christine A